Albuferon

albuferon · Human Genome Sciences Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Albuferon, covering 2013-08-02 to 2013-11-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1 [Phase 2]